Követés
Галина Соляник
Галина Соляник
Институт экспериментальной патологии, онкологии им радиобиологии
E-mail megerősítve itt: onconet.kiev.ua
Cím
Hivatkozott rá
Hivatkozott rá
Év
Surface enhanced IR absorption of nucleic acids from tumor cells: FTIR reflectance study
GI Dovbeshko, VI Chegel, NY Gridina, OP Repnytska, YM Shirshov, ...
Biopolymers: Original Research on Biomolecules 67 (6), 470-486, 2002
2422002
Multifactorial nature of tumor drug resistance
GI Solyanik
Exp Oncol 32 (3), 181-5, 2010
832010
Anticancer activity of aconitine-containing herbal extract BC1
GI Solyanik, AG Fedorchuk, ON Pyaskovskaya, OI Dasyukevitch, ...
Exp Oncol 26 (4), 307-311, 2004
602004
A mathematical model of periodic processes in membranes (with application to cell cycle regulation)
DS Chernavskii, EK Palamarchuk, AA Polezhaev, GI Solyanik, ...
BioSystems 9 (4), 187-193, 1977
481977
Different growth patterns of a cancer cell population as a function of its starting growth characteristics: analysis by mathematical modelling
GI Solyanik, NM Berezetskaya, RI Bulkiewicz, GI Kulik
Cell proliferation 28 (5), 263-278, 1995
421995
Changes in VEGF level and tumor growth characteristics during Lewis lung carcinoma progression towards cis-DDP resistance
ON Pyaskovskaya, OI Dasyukevich, DL Kolesnik, LV Garmanchouk, ...
Experimental oncology, 2007
352007
Analysis of growth kinetics and proliferative heterogeneity of Lewis lung carcinoma cells growing as unfed culture
ON Pyaskovskaya, DL Kolesnik, AV Kolobov, SI Vovyanko, GI Solyanik
Experimental Oncology, 2008
342008
Quinazoline compounds for antitumor treatment
GI Solyanik
Experimental oncology 41 (1), 3-6, 2019
272019
Influence of aconitine-containing herbal extract BC1 on proliferative and electrokinetic characteristics of endothelial cells.
LV Garmanchouk, ON Pyaskovskaya, YV Yanish, VA Shlyakhovenko, ...
Experimental oncology 27 (4), 262-266, 2005
242005
Cisplatin-resistant Lewis lung carcinoma cells possess increased level of VEGF secretion
GI Solyanik, ON Pyaskovskaya, LV Garmanchouk
Экспериментальная онкология 25 (4), 260-265, 2003
232003
Comparative study of anticancer efficacy of aсonitinecontaining agent BC1 against ascite and solid forms of Ehrlich’s carcinoma
OI Dasyukevich, GI Solyanik
Experimental Oncology, 2007
222007
The role of cell motility in metastatic cell dominance phenomenon: analysis by a mathematical model
AV Kolobov, AA Polezhaev, GI Solyanik
Computational and Mathematical Methods in Medicine 3, 63-77, 2000
222000
Effectiveness of sodium dichloroacetate against glioma С6 depends on administration schedule and dosage
AG Fedorchuk, ON Pyaskovskaya, GV Gorbik, IV Prokhorova, DL Kolesnik, ...
Experimental oncology, 2016
202016
The SEIRA spectroscopy data of nucleic acids and phospholipids from sensitive-and drug-resistant rat tumours.
VF Chekhun, GI Solyanik, GI Kulik, VP Tryndiak, IN Todor, GI Dovbeshko, ...
Journal of Experimental & Clinical Cancer Research: CR 21 (4), 599-607, 2002
192002
2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma
ON Pyaskovskaya, DL Kolesnik, AG Fedorchuk, IV Prochorova, ...
Experimental Oncology, 2016
172016
The evaluation of prooxidant and antioxidant state of two variants of lewis lung carcinoma: a comparative study
LV Sorokina, GI Solyanik, TV Pyatchanina
Experimental Oncology, 2010
162010
Paraneoplastic syndrome in mice bearing high-angiogenic variant of Lewis lung carcinoma: relations with tumor derived VEGF
OG Fedorchuk, OM Pyaskovskaya, LM Skivka, GV Gorbik, OO Trompak, ...
Cytokine 57 (1), 81-88, 2012
152012
Relation of the intensity of metabolism with the process of determination in embryonic cell: Comparison of the Experimental Data with Theory
DS Chernavskii, GI Solyanik, LV Belousov
Biological Cybernetics 37 (1), 9-18, 1980
151980
Resistance of Guerin's carcinoma cells to cisplatine: Biochemical and morphological aspects
OV Yurchenko, IN Todor, VP Tryndyak, NA Tregubova, OV Kovtonyuk, ...
Экспериментальная онкология 25 (1), 64-68, 2003
142003
Metformin enhances antitumor action of sodium dichloroacetate against glioma C6
DL Kolesnik, ON Pyaskovskaya, OV Yurchenko, GI Solyanik
Experimental Oncology 41 (2), 123-129, 2019
132019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20